Top Acquisitions that Hit The Pharma Industry in 2023
The year 2023, marked by the persistent echoes of the COVID-19 pandemic, unfolded as a rollercoaster for the health sector, with the pharmaceutical industry at the forefront.
Amidst the resurgence of integrative and precision medicines, and the expanding API business, the pharma sector witnessed a dynamic spectrum, ranging from groundbreaking drug developments to successful commercialisation.
Unlock the Future of Digital Health — Free for 60 Days!
Join DHN Plus and access exclusive news, intelligence reports, and deep-dive research trusted by healthtech leaders.
Already a subscriber? Log in
Subscribe Now @ ₹499.00Stay tuned for more such updates on Digital Health News
Follow us
